P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Authors: J. H. Jang, R. Demichelis Gomez, H. Bumbea, L. Nogaieva, L. L. L. Wong, S. M. Lim, J. Park, Y. Kim, S. Cho